![logo-tridek-one](https://ala.associates/wp-content/uploads/2022/09/logo-tridek-one.png)
Description
Tridek-One is a private biotechnology company formed out of INSERM (Paris, France), developing first-in-class immune checkpoint agonists to restore the immune balance in patients living with auto-immune diseases.
See the website
Case studies
Tridek-One SAS is a leading biotech start-up specialized in the research and development of CD31 agonists to restore the immune balance
Read more